Course Code: BP106T
Unit II Introduction
Acid-base chemistry and physiological electrolytes connect chemical equilibrium with pharmaceutical formulation and body-fluid balance. This unit explains pH, buffers, isotonicity and the functions of important ions.
Buffer equations predict approximate pH from conjugate-partner ratios. Tonicity describes a solution’s sustained effect on cell volume and requires separate consideration in intravenous and ophthalmic preparations.
Replacement salts and oral rehydration solutions supply specific ions rather than interchangeable amounts of salt. Chemical buffers, ventilation and renal function work together to maintain physiological acid-base balance.
Topics Covered – Complete Syllabus Map
| Required topic | Notes sections |
|---|---|
| Acids, bases and conjugate pairs | 1 |
| pH scale and significance | 2 |
| Buffers and buffer equations | 3 |
| Buffer pH calculations | 4 |
| Isotonicity principles | 5 |
| Tonicity adjustment calculations | 6 |
| IV and ophthalmic applications | 7 |
| Major physiological ions | 8 |
| Replacement therapy and mEq | 9 |
| NaCl, KCl and CaCl2 | 10–12 |
| Oral Rehydration Salts | 13 |
| Physiological acid-base balance | 14–15 |
| Integrated revision and calculations | 16; final revision |
Learning outcomes
Define acids, bases, conjugate pairs and buffers.
Interpret the logarithmic pH scale and its applications.
Calculate buffer pH and explain buffer capacity.
Distinguish tonicity from total particle concentration.
Calculate isotonicity adjustments with suitable methods.
Explain major extracellular and intracellular ions.
Compare NaCl, KCl, CaCl2 and the ORS formula.
Convert salt amounts to mmol and mEq correctly.
Explain regulation by buffers, lungs and kidneys.
Essential vocabulary
| Term | Meaning |
|---|---|
| Conjugate pair | Species differing by one proton |
| pH | Negative logarithm of H+ activity |
| Buffer | System resisting large pH changes |
| Buffer capacity | Resistance to pH change per added acid/base |
| Tonicity | Sustained effect on cell volume |
| Isotonic | No sustained osmotic volume change |
| Electrolyte | Substance producing ions in solution |
| mEq | Millimoles multiplied by ionic valence |
| ORS | Defined glucose-electrolyte oral mixture |
| Acidemia | Measured blood pH below the normal range |
Central question How do pH, effective osmotic action and ionic composition determine a solution’s pharmaceutical and physiological behaviour?
1. Acids and bases
1.1 Arrhenius concept
An Arrhenius acid increases the concentration of hydrogen ions in aqueous solution. In water, a proton is hydrated; H3O+ is a useful representation. An Arrhenius base increases hydroxide-ion concentration in water.
HCl + H2O → H3O+ + Cl-
NaOH → Na+ + OH-
Neutralization combines hydronium and hydroxide to form water: H3O+ + OH- → 2H2O. Counterions remain in solution unless another reaction occurs.
This concept is useful for aqueous solutions but is too restricted to explain all acid-base reactions, especially those occurring without water or without OH- as a reactant.
1.2 Proton-transfer concept
A proton-donating species is an acid; a proton-accepting species is a base. Acid-base reactions form conjugate pairs that differ by one proton.
HA + H2O ⇌ H3O+ + A-
Here HA/A- is one conjugate pair and H3O+/H2O is the other. The conjugate base is the species remaining after acid donation.
NH3 + H2O ⇌ NH4+ + OH-
Ammonia accepts H+ and is therefore a base even though its formula contains no hydroxide group. NH4+ is its conjugate acid.
1.3 Electron-pair concept
A Lewis acid accepts an electron pair; a Lewis base donates an electron pair. This extends acid-base behaviour beyond proton transfer.
BF3 + :NH3 → F3B←NH3
The nitrogen lone pair is donated to electron-deficient boron. The arrow represents formation of a coordinate bond from donor to acceptor.
1.4 Amphiprotic substances
An amphiprotic substance can donate or accept a proton depending on the reacting partner. Water and HCO3- are examples.
HCO3- + H+ → H2CO3
HCO3- + OH- → CO3^2- + H2O
Amphoteric is a broader term for substances behaving as either acids or bases; amphiprotic specifically concerns proton transfer.
Diagram labels: Proton transfer and conjugate pairs; H; Cl; O; H; H; H+ accepted by water; HCl: acid; H2O: base; Cl-; H3O+; Conjugate base; Conjugate acid; HCl / Cl- differ by one H+; H2O / H3O+ differ by one H+.
| Concept | Acid and base definition |
|---|---|
| Arrhenius | Acid raises H3O+; base raises OH- in water |
| Proton transfer | Acid donates H+; base accepts H+ |
| Electron pair | Acid accepts a pair; base donates a pair |
1.5 Strong and weak species
Strong acids and bases ionize or dissociate essentially completely under ordinary dilute aqueous conditions. Weak species establish an equilibrium with appreciable unionized material.
Strong acid examples: HCl and HNO3.
Weak acid examples: CH3COOH and H2CO3.
Strong base examples: NaOH and KOH.
Weak base example: NH3. Strength and concentration are different. Strength concerns the tendency to ionize; concentration concerns how much material is present per unit volume. A dilute strong acid and a concentrated weak acid cannot be ranked by concentration labels alone.
1.6 Acid and base constants
For HA ⇌ H+ + A-, the dilute-solution concentration approximation is Ka = [H+][A-]/[HA]. Activities are used in the rigorous thermodynamic expression.
For B + H2O ⇌ BH+ + OH-, Kb = [BH+][OH-]/[B]. Water activity is incorporated into the constant.
pKa = −log10Ka; pKb = −log10Kb.
A larger Ka means a stronger acid; a smaller pKa means a stronger acid. For a conjugate acid-base pair, KaKb = Kw and pKa + pKb = pKw at the same temperature.
Memory key Removing H+ gives the conjugate base; adding H+ gives the conjugate acid. Check both the number of hydrogens and the electric charge.
2. pH scale and significance
2.1 Definition
pH is the negative base-10 logarithm of hydrogen-ion activity: pH = −log10a(H+). For dilute ideal aqueous calculations, pH ≈ −log10[H+], where the numerical concentration is expressed relative to 1 mol/L.
pOH ≈ −log10[OH-]. At 25°C, Kw ≈ 1.0 × 10^-14 and pH + pOH ≈ 14.00.
Neutrality means [H+] = [OH-]. The neutral pH equals pKw/2 and changes with temperature. Neutral pH is approximately 7 at 25°C; it is not always exactly 7.
2.2 Logarithmic meaning
A fall of one pH unit corresponds to a tenfold rise in hydrogen-ion activity. A solution at pH 3 has approximately 100 times the H+ activity of a solution at pH 5.
The commonly shown range 0–14 is convenient for many aqueous solutions. Values outside it are possible; very concentrated solutions require careful activity-based interpretation.
2.3 Pharmaceutical importance
Stability: hydrolysis and other degradation reactions may accelerate at particular pH values.
Solubility: ionization changes the aqueous solubility of many weak acids and bases.
Absorption: ionized and unionized fractions influence membrane transport; pH alone does not determine absorption.
Comfort: strongly acidic or alkaline preparations can irritate tissues.
Preservation: antimicrobial preservative activity may depend on pH.
Diagram labels: Logarithmic pH scale at 25°C; 0; 2; 4; 6; 8; 10; 12; 14; Acidic; Alkaline; Neutral: pH 7; pH 3: [H+] ≈ 10^-3 mol/L; pH 5: [H+] ≈ 10^-5 mol/L; pH 3 has 100 × the H+ activity of pH 5 (dilute ideal approximation).
- Analysis: pH affects indicators, precipitation, complexation and titration endpoints. A formulation pH is selected using stability, solubility, route, compatibility and tolerability together. Physiological pH is not automatically the best storage pH for every medicine.
2.4 Strong-acid numerical
For 0.0010 mol/L HCl, assume complete dissociation and neglect water autoionization. [H+] = 1.0 × 10^-3 mol/L.
pH = −log10(10^-3) = 3.00.
This shortcut becomes unsuitable for extremely dilute acid, where water contributes significant H+, and for concentrated nonideal solutions.
2.5 Strong-base numerical
For 0.020 mol/L NaOH, [OH-] ≈ 0.020 mol/L. pOH = −log10(0.020) = 1.70.
At 25°C, pH = 14.00 − 1.70 = 12.30.
Use hydroxide stoichiometry: one mole of NaOH gives one mole of OH-. Other bases may have different stoichiometry or incomplete dissolution.
2.6 Weak-acid approximation
For a weak monoprotic acid of initial concentration C, let x = [H+]. Then Ka = x^2/(C − x), neglecting water autoionization. If x is small relative to C, x ≈ √(KaC).
Example: C = 0.10 mol/L and Ka = 1.8 × 10^-5. [H+] ≈ √(1.8 × 10^-6) = 1.34 × 10^-3 mol/L; pH ≈ 2.87.
Here x/C ≈ 1.34%, so the approximation is reasonable. If dissociation is not small, solve the quadratic; the square-root shortcut is not universal.
2.7 Measuring pH
A glass-electrode pH meter measures a potential related to H+ activity against a reference system. A combination electrode contains both the sensing and reference assemblies.
Calibrate with suitable certified buffers that bracket the sample pH when practicable.
Rinse the electrode, gently blot and immerse the sensing bulb and reference junction in the sample.
Allow the reading to stabilize; record temperature and avoid carryover.
Do not wipe aggressively, strike the bulb or let an electrode dry contrary to its storage instructions.
Diagram labels: Combination glass-electrode pH meter; pH 7.00; Glass bulb; Reference junction; Sample solution; Combination electrode; Rinse, calibrate and allow stabilization.
Indicator papers give approximate ranges; a calibrated meter is preferred for quantitative work. Temperature compensation corrects electrode response but does not remove the actual temperature dependence of sample pH.
Numerical checklist Identify acid or base → check dissociation assumptions → obtain H+ or OH- → take log10 → apply pKw if needed → report temperature and suitable precision.
3. Buffers and buffering action
3.1 Definition and composition
A buffer resists a large pH change when small amounts of strong acid or base are added. A typical buffer contains a weak acid with its conjugate base, or a weak base with its conjugate acid, in appreciable amounts.
| Buffer type | Example pair |
|---|---|
| Acidic | CH3COOH / CH3COO- from sodium acetate |
| Basic | NH3 / NH4+ from ammonium chloride |
| Phosphate | H2PO4- / HPO4^2- |
| Physiological bicarbonate | Dissolved CO2 / HCO3- system |
Mixing arbitrary acids and salts does not necessarily produce a useful buffer. The pair must be conjugate partners, compatible and present in sufficient amounts.
3.2 Acidic buffer mechanism
In an acetate buffer, acetic acid supplies the proton-donating reserve and acetate supplies the proton-accepting reserve.
On adding acid: CH3COO- + H+ → CH3COOH.
On adding base: CH3COOH + OH- → CH3COO- + H2O.
Added strong acid or base is converted mainly into a weak species. The ratio changes, so the pH changes slightly; a buffer does not keep pH absolutely constant.
3.3 Basic buffer mechanism
For NH3/NH4+, added acid is consumed by ammonia: NH3 + H+ → NH4+.
Added base is consumed by ammonium: NH4+ + OH- → NH3 + H2O.
The weak base and conjugate acid must both remain after any reaction. If one is exhausted, the buffer equation no longer describes a functioning buffer.
3.4 Buffer equation: derivation
For HA ⇌ H+ + A-, Ka = [H+][A-]/[HA]. Rearranging gives [H+] = Ka[HA]/[A-].
Taking negative logarithms gives the acid-buffer equation:
Diagram labels: Two chemical reserves of an acid buffer; Added H+; HA + A-; Buffer; Added OH-; HA + A-; Buffer; A- + H+ → HA; HA + OH- → A- + H2O; Conjugate base consumes acid; Weak acid consumes base.
pH = pKa + log10([A-]/[HA]).
The expression uses equilibrium concentrations as an approximation to activities. In ordinary buffer calculations, analytical concentrations approximate them when ionization and water contributions are small relative to the buffer components.
The common shorthand is pH = pKa + log10(salt/acid). It is valid when the salt supplies the conjugate base without a complicating reaction. Use molar concentrations or mole ratios, not unequal molecular masses as a direct mass ratio.
3.5 Basic buffer equation
Kb = [BH+][OH-]/[B]. Therefore:
pOH = pKb + log10([BH+]/[B]).
Then pH = pKw − pOH. Alternatively, use pH = pKa(BH+) + log10([B]/[BH+]); both approaches agree at the same temperature.
3.6 Buffer range and capacity
The useful range is commonly approximately pKa ± 1, corresponding to conjugate-base/acid ratios between 0.1 and 10. This is a guideline, not a sharp boundary.
Buffer capacity expresses how much strong acid or base is required per unit volume to change pH by one unit. A differential expression is β = dn/(V dpH), where n is added strong-base equivalents; the acid-addition magnitude may be expressed similarly.
Capacity increases with total buffer concentration.
For a simple conjugate pair at fixed total concentration, capacity is greatest near equal acid/base concentrations, where pH ≈ pKa.
Dilution ideally changes the ratio little, but lowers the amount of reserve per unit volume and therefore capacity.
Temperature, ionic strength and additional equilibria can alter the actual pH and capacity.
Diagram labels: Buffer pH depends on conjugate ratio; -2; -2; -1; -1; 0; 0; 1; 1; 2; 2; pH − pKa; log10([A-]/[HA]); Shading: ratio 0.1–10 (pKa ± 1).
3.7 Selecting a pharmaceutical buffer
Choose a suitable pKa near the target pH, acceptable ingredients, adequate but not excessive capacity, and compatibility with the drug and packaging. Verify stability, preservative effectiveness and route suitability.
Phosphate, citrate and acetate systems are common examples. Their suitability is product-specific. Polyprotic acids have several dissociation constants; choose the conjugate pair relevant to the target pH.
In ophthalmic preparations, excessive buffer capacity may oppose the tears’ ability to adjust the drop’s pH, increasing discomfort. Tonicity and pH must be evaluated separately.
Avoid this mistake Equal concentrations of a weak acid and its conjugate base give pH ≈ pKa, not necessarily pH 7.
4. Buffer calculations
4.1 Direct acidic-buffer calculation
An acetate buffer contains 0.10 mol/L acetic acid and 0.20 mol/L acetate. Given pKa = 4.76, calculate the pH.
pH = 4.76 + log10(0.20/0.10)
= 4.76 + 0.301 = 5.06.
The larger conjugate-base concentration raises pH above pKa. The concentrations must refer to the same final solution.
4.2 Finding the required ratio
For an acid of pKa 4.76, a target buffer pH is 5.00. Rearranging:
[A-]/[HA] = 10^(pH − pKa)
= 10^0.24 = 1.74.
If the total buffer concentration is 0.100 mol/L, let [HA] = x and [A-] = 1.74x. Then 2.74x = 0.100, so [HA] = 0.0365 mol/L and [A-] = 0.0635 mol/L.
For 1 L these correspond to 0.0365 mol acid and 0.0635 mol conjugate base. Convert moles to mass using the correct chemical and hydrate form. Make to the final volume and verify actual pH experimentally.
4.3 Basic-buffer calculation
A solution contains 0.10 mol/L NH3 and 0.20 mol/L NH4+. Given pKb = 4.75 at 25°C:
pOH = 4.75 + log10(0.20/0.10) = 5.05.
pH = 14.00 − 5.05 = 8.95.
The conjugate-acid concentration is in the numerator of the pOH equation. Reversing this ratio is a frequent error.
4.4 Adding strong acid
A 100 mL acetate buffer initially contains 0.010 mol HA and 0.010 mol A-. Add 0.001 mol HCl, assuming negligible volume change and pKa 4.76.
First perform the stoichiometric reaction: A- + H+ → HA.
| Component | Moles after reaction |
|---|---|
| A- | 0.010 − 0.001 = 0.009 |
| HA | 0.010 + 0.001 = 0.011 |
Then pH = 4.76 + log10(0.009/0.011) = 4.67. Initial pH was 4.76; the fall is approximately 0.09 unit.
Mole ratios are convenient because both components have the same final volume. A common volume cancels from their concentration ratio.
4.5 Adding strong base
For the same initial buffer, add 0.002 mol NaOH instead. HA + OH- → A- + H2O.
Remaining HA = 0.008 mol; A- = 0.012 mol.
pH = 4.76 + log10(0.012/0.008) = 4.94.
Do not insert the initial ratio into the buffer equation after adding acid or base. Reaction comes first, equilibrium calculation follows.
4.6 Buffer exhaustion
If 0.012 mol HCl is added to a buffer containing only 0.010 mol A-, the base reserve is consumed and 0.002 mol strong acid remains. The ordinary buffer-ratio expression is invalid because A- is effectively exhausted.
The remaining strong acid, weak acid, final volume and equilibrium determine the resulting pH. A negative calculated amount of a component is a warning that the assumed buffer calculation cannot be used.
4.7 Mixing volumes
Mix 50 mL of 0.10 mol/L HA with 100 mL of 0.10 mol/L A-. Moles HA = 0.0050; moles A- = 0.0100.
The final ratio is 2.00, so pH = pKa + 0.301. For pKa 4.76, pH = 5.06. Do not compare the original stock concentrations without including their different volumes.
4.8 Dilution
Diluting an ideal buffer tenfold leaves its acid/base ratio unchanged, so calculated pH is nearly unchanged. Each component concentration falls tenfold, however, so the buffering reserve per millilitre is much smaller.
Real buffers can show a pH shift on dilution because activity coefficients and dissociation effects change. The ratio rule is a useful approximation, not an experimental guarantee.
4.9 Calculation workflow
Write the correct conjugate pair and appropriate pKa or pKb.
Convert stated amounts and volumes to moles.
Complete any neutralization reaction first.
Check that both components remain appreciably present.
Calculate the ratio and logarithm; state the assumptions.
Check whether the answer is above or below pKa as expected.
Practice with answers For pKa 4.76, ratios A-/HA of 0.10, 1.00 and 10.0 give pH 3.76, 4.76 and 5.76. A desired pH of 4.46 requires a ratio of approximately 0.50.
5. Isotonicity and osmotic principles
5.1 Osmosis and osmotic pressure
Osmosis is the movement of water across a selectively permeable membrane in response to differences in water chemical potential. In a simple cell model, water moves toward the side containing the greater concentration of effectively nonpenetrating solute particles.
For a dilute ideal solution, osmotic pressure is approximated by π = iCRT, where i is the effective particle factor, C the molar concentration, R the gas constant and T absolute temperature.
Electrolytes produce more than one ion per formula unit. Ideal NaCl yields two particles and ideal CaCl2 yields three; real solutions show deviations due to interionic effects.
5.2 Osmolarity, osmolality and tonicity
| Term | Meaning |
|---|---|
| Osmolarity | Osmoles of dissolved particles per litre of solution |
| Osmolality | Osmoles per kilogram of solvent |
| Tonicity | Effect of a solution on cell volume across a specified membrane |
| Isotonic | No sustained osmotic change in cell volume |
| Hypotonic | Causes water entry and cell swelling |
| Hypertonic | Causes water loss and cell shrinkage |
Tonicity mainly reflects solutes that do not freely cross the relevant membrane. An iso-osmotic solution may not be isotonic if its solute enters cells readily. Always specify the biological membrane and exposure conditions.
5.3 Effect on erythrocytes
In an isotonic medium, erythrocytes retain their normal biconcave form. In a hypotonic medium they swell; sufficiently severe swelling causes haemolysis. In a hypertonic medium water leaves the cells, causing shrinkage and crenation.
Diagram labels: Erythrocyte response to tonicity; Isotonic; No sustained volume change; Hypotonic; Water enters; cell swells; Hypertonic; Water leaves; cell shrinks; H2O; Severe swelling may cause haemolysis.
5.4 Pharmaceutical importance
IV preparations enter directly into the circulation, making composition, osmotic properties, sterility, endotoxin control and compatibility important. Ophthalmic solutions contact sensitive ocular tissues and require suitable tonicity and pH.
0.9% w/v sodium chloride is the common reference isotonic saline: 0.9 g in 100 mL final solution, or 9 g/L. Its calculated osmolarity is approximately 308 mOsm/L. Its clinical isotonic classification and calculated ideal osmolarity should not be confused with exact equality to every measured plasma value.
Not every IV solution is formulated to be isotonic. Hypertonic products have specific clinical indications and administration requirements. A tonicity calculation alone does not authorize clinical preparation or administration.
5.5 Two approaches to adjustment
Class I methods calculate an amount of adjusting agent to add: sodium chloride equivalent and freezing-point depression methods.
Class II methods first determine the volume in which the ingredients themselves form an isotonic solution, then add an isotonic vehicle to the prescribed final volume: White–Vincent and its tabular simplification.
This distinction helps explain why plain water must not simply be added after an initially isotonic solution is formed: it would dilute the effective solutes and reduce tonicity.
6. Calculating isotonicity adjustment
6.1 Sodium chloride equivalent
The sodium chloride equivalent, E, is the mass of NaCl producing approximately the same osmotic effect as 1 g of a substance under specified conditions. It is dimensionless when expressed as g NaCl/g substance.
For final volume V mL, the NaCl equivalent needed for isotonicity is 0.009V grams.
NaCl to add (g) = 0.009V − Σ(wE).
w is the mass in grams of each dissolved ingredient. Include all osmotically relevant constituents for which the method supplies applicable E values.
The result is a formulation estimate. Use appropriate verified E data for the actual chemical form and formulation conditions; the numerical E values in the following exercises are illustrative.
6.2 Worked example: one ingredient
Prepare 100 mL containing 1.00 g of an illustrative drug with E = 0.20.
Target NaCl equivalent = 0.009 × 100 = 0.900 g.
Drug contribution = 1.00 × 0.20 = 0.200 g.
NaCl to add = 0.900 − 0.200 = 0.700 g.
The final volume is 100 mL; the instruction is not to add 100 mL water to the solids. A real sterile product requires a validated manufacturing process.
6.3 Worked example: two ingredients
For 30 mL, an illustrative formulation contains 0.30 g of X (E 0.18) and 0.15 g of Y (E 0.25).
Target = 0.009 × 30 = 0.270 g.
Contributions = (0.30 × 0.18) + (0.15 × 0.25) = 0.054 + 0.0375 = 0.0915 g.
NaCl to add = 0.270 − 0.0915 = 0.1785 g, approximately 0.179 g.
6.4 Negative result
For 100 mL containing 5.0 g of an illustrative ingredient of E 0.20, contribution = 1.0 g NaCl equivalent. Target is 0.9 g, giving −0.1 g.
Do not add a negative mass. The existing solution is above the method’s isotonic target. Reassess concentration, final volume or formulation; adding more NaCl worsens the excess.
6.5 Freezing-point depression
Freezing-point depression is a colligative property. The conventional isotonic reference for blood and tears is a depression of approximately 0.52°C. A 1% w/v NaCl solution produces approximately 0.576°C depression under the usual instructional convention.
If the dissolved ingredients already cause a depression ΔTdrug, then:
NaCl to add (% w/v) = (0.52 − ΔTdrug)/0.576.
For multiple ingredients, sum their applicable freezing-point depressions before subtraction. The values are approximations used in formulation calculations, not universal constants for all mixtures.
6.6 Cryoscopic worked example
An illustrative 1% drug solution depresses the freezing point by 0.10°C.
Required additional depression = 0.52 − 0.10 = 0.42°C.
NaCl concentration to add = 0.42/0.576 = 0.729% w/v.
For 50 mL, NaCl mass = 0.729 × 50/100 = 0.365 g approximately. The percentages refer to final solution volume.
6.7 White–Vincent method
The volume of isotonic solution formed by the drug ingredients alone is:
Viso (mL) = 111.1 Σ(wE).
This follows from Σ(wE) grams being equivalent to 0.009Viso grams of NaCl. Dissolve the ingredients and add water to Viso; then use an appropriate isotonic vehicle to reach the prescribed final volume.
Example: w = 0.30 g and E = 0.20 give Viso = 111.1 × 0.060 = 6.67 mL. For a final volume of 30 mL, add suitable isotonic vehicle to 30 mL after making the drug solution to 6.67 mL with water.
The remaining vehicle volume is approximately 23.33 mL if volumes are additive. Making to a final volume is more reliable than assuming exact volume additivity.
Diagram labels: Isotonic-volume method; Drug ingredients + water; To Viso; Viso = 111.1 Σ(wE) mL; Isotonic vehicle; Final volume; Use isotonic vehicle after the first step.
6.8 Tabular simplification
The Sprowls method is a tabular simplification of the same volume principle. Tables commonly give an isotonic volume for a specified reference mass, often 0.3 g; scale the table value to the actual amount.
For an illustrative E of 0.20, a 0.3 g reference mass corresponds to 6.67 mL. A 0.6 g mass therefore corresponds to 13.33 mL. Always confirm the table’s reference mass and chemical form.
| Method | Main calculation |
|---|---|
| NaCl equivalent | Subtract ingredient NaCl equivalents from 0.009V |
| Freezing-point depression | Supply the missing depression to about 0.52°C |
| White–Vincent | Water to calculated isotonic volume, then isotonic vehicle |
| Tabular method | Scale the listed isotonic volume by ingredient mass |
Do not confuse the methods Class I calculates adjusting salt to add. Class II calculates an initial isotonic volume, followed by an isotonic diluent. If Viso exceeds the prescribed volume, the specified formulation cannot be corrected by this dilution sequence as written.
7. IV fluids and ophthalmic solutions
7.1 Intravenous preparations
IV fluids supply water, electrolytes or other therapeutically required components directly to the circulation. Their pharmaceutical quality includes sterility, appropriate endotoxin control, particulate control, composition, container integrity and compatibility.
Tonicity influences water movement between plasma and cells. Very hypotonic exposure may damage erythrocytes; excessive hypertonicity changes cell volume and can injure or irritate tissues depending on administration conditions.
7.2 Saline and glucose solutions
0.9% NaCl supplies both sodium and chloride and is commonly classified as isotonic. It does not supply potassium, glucose or all other physiological electrolytes.
A 5% glucose preparation may be approximately iso-osmotic in its container depending on formulation. Once glucose is taken up and metabolized, the remaining water can have a hypotonic physiological effect. Container osmolarity and the later effect in the body are different considerations.
Balanced electrolyte fluids contain a combination of ions and often metabolizable anions. Their composition differs from normal saline; the appropriate fluid depends on clinical and laboratory assessment.
7.3 Ophthalmic preparations
Eye drops contact the tear film, cornea and conjunctiva. Suitable pH, buffer capacity and tonicity improve tolerability, but drug stability and solubility may impose formulation constraints.
Tears can dilute a drop and buffer a limited amount of acidity or alkalinity.
A large buffer reserve may prolong an unsuitable pH at the ocular surface.
Tonicity agents include sodium chloride and other suitable, compatible substances.
Sterility, particles and preservative suitability are essential additional considerations.
Diagram labels: Tear film and corneal surface: section; Tear film; Epithelium; Corneal stroma; Inner corneal surface; Outside; Aqueous humour; Section enlarged; layer thickness simplified.
The approximate 0.52°C freezing-point depression is a teaching reference for isotonic adjustment. It does not define all acceptable ophthalmic products; tolerability depends on concentration, contact time and the complete formulation.
7.4 Joint formulation checks
| Check | Question to answer |
|---|---|
| pH | Does it support stability, solubility and route tolerability? |
| Buffer capacity | Is the reserve sufficient without being excessive? |
| Tonicity | What effective osmotic action occurs at the relevant membrane? |
| Compatibility | Will ions, buffer or packaging cause precipitation or degradation? |
| Quality | Are sterility, endotoxins and particulates appropriately controlled? |
Isotonic does not mean sterile, nonirritating, compatible or clinically appropriate. Each property requires its own assessment.
8. Major physiological electrolytes
8.1 Body-fluid compartments
Intracellular fluid is inside cells. Extracellular fluid includes interstitial fluid and plasma; plasma is the liquid portion of blood. Compartments differ in ionic composition while remaining approximately electrically neutral overall.
Sodium is the dominant extracellular cation; chloride and bicarbonate are important extracellular anions. Potassium is the dominant intracellular cation; phosphate and negatively charged proteins are important intracellular anions. Magnesium is also important within cells.
Diagram labels: Ion gradients across a cell membrane; Extracellular fluid; Na+; Cl-; HCO3-; Intracellular fluid; K+; phosphates; proteins; Plasma membrane; Gradients are maintained by transport proteins.
The plasma membrane is selectively permeable. Transport proteins and the Na+/K+-ATPase help maintain gradients; water distribution depends on osmotic forces and compartment barriers.
8.2 Sodium: Na+
Main extracellular cation and a major contributor to extracellular osmotic balance.
Supports nerve impulses and muscle activity through ion gradients.
Drives transport of nutrients such as glucose through coupled transport. Total body sodium influences extracellular fluid volume; measured serum sodium also reflects water balance. A concentration change cannot be interpreted as a simple change in sodium stores alone.
8.3 Potassium: K+
Main intracellular cation; helps establish membrane potential.
Required for nerve transmission, muscle contraction and normal cardiac electrical activity.
Supports enzyme activity and cellular metabolism. Small changes in extracellular potassium can significantly affect excitable tissues. Both deficiency and excess require assessment; renal function influences potassium handling.
8.4 Calcium: Ca2+
Calcium contributes to bone and tooth mineral, muscle contraction, neurotransmitter release, cellular signalling and blood coagulation. Most body calcium is stored in mineralized tissues; extracellular ionized calcium is the biologically active fraction.
Some circulating calcium is protein-bound. Total calcium and ionized calcium are different measurements, and acid-base changes can alter protein binding.
8.5 Magnesium: Mg2+
Magnesium is a cofactor for many enzymes, participates in ATP-associated reactions and supports neuromuscular function. Much of it is intracellular or in bone. Deficiency can accompany or aggravate abnormalities of other ions, including potassium.
8.6 Chloride: Cl-
Chloride is a principal extracellular anion. It contributes to electrical neutrality, osmotic balance, acid-base relationships and gastric hydrochloric acid formation.
Movement of chloride and bicarbonate between erythrocytes and plasma assists carbon dioxide transport. Chloride is more than a chemically inactive counterion.
8.7 Bicarbonate: HCO3-
Bicarbonate is a major component of the extracellular acid-base buffer system. Its concentration is regulated by metabolism, respiration and renal function. It is linked to dissolved CO2 and cannot be understood independently of ventilation.
8.8 Phosphate and proteins
Phosphates participate in ATP, nucleic acids, bone mineral and intracellular buffering. The H2PO4-/HPO4^2- pair also buffers acid in renal tubular fluid.
Proteins carry ionizable groups that accept or release H+. Intracellular proteins and haemoglobin contribute substantially to buffering. Plasma proteins also influence distribution of fluid across capillary walls.
| Ion | Key examination function |
|---|---|
| Na+ | Extracellular volume and osmotic balance |
| K+ | Intracellular potential and cardiac electrical function |
| Ca2+ | Contraction, signalling, coagulation and mineral |
| Mg2+ | Enzyme and ATP-associated functions |
| Cl- | Extracellular anion, gastric acid and ionic balance |
| HCO3- | Extracellular acid-base regulation |
| Phosphates | Intracellular buffering, ATP and bone |
Exam distinction An electrolyte is an ion-producing substance in solution. A physiological ion is the charged species itself. NaCl supplies Na+ and Cl-; they have separate functions despite being supplied by the same salt.
9. Replacement therapy and units
9.1 Purpose
Electrolyte replacement restores deficits caused by gastrointestinal loss, renal loss, inadequate intake or other disturbances. The chosen salt, route, concentration and monitoring depend on the actual deficit, fluid status, renal function and clinical context.
An oral product and an injectable product containing the same chemical name are not interchangeable. Injectables require appropriate pharmaceutical quality and controlled administration.
9.2 Moles, millimoles and equivalents
Moles measure the amount of substance. A millimole is 10^-3 mol. An equivalent expresses the amount of ionic charge involved; a milliequivalent is 10^-3 equivalent.
mmol = mass (mg) / molar mass (g/mol).
The numerical units work because 1 mmol of a compound of molar mass M weighs M mg.
mEq of an ion = mmol of that ion × absolute valence.
For Na+, K+ and Cl-, 1 mmol = 1 mEq. For Ca2+ or Mg2+, 1 mmol = 2 mEq.
9.3 NaCl example
0.9 g NaCl in 100 mL means 900 mg/58.44 = 15.40 mmol NaCl. This supplies 15.40 mEq Na+ and 15.40 mEq Cl- in 100 mL.
For 1 L, it supplies approximately 154 mEq/L of each ion. The ideal particle concentration is 2 × 154 ≈ 308 mOsm/L.
Do not report 308 mEq/L of sodium: that number sums ideal dissolved particles, not sodium charge.
9.4 KCl example
For 0.7455 g KCl, mass = 745.5 mg and molar mass = 74.55 g/mol.
mmol = 745.5/74.55 = 10.00.
It supplies 10.00 mEq K+ and 10.00 mEq Cl-. This calculation expresses composition; it is not an instruction to administer a dose.
9.5 Calcium chloride example
For 147.02 mg CaCl2·2H2O, amount = 1.00 mmol salt. It supplies 1.00 mmol Ca2+ = 2.00 mEq Ca2+, and 2.00 mmol Cl- = 2.00 mEq Cl-.
The salt’s molar mass includes water of crystallization. Using anhydrous CaCl2 mass, 110.98 g/mol, for a dihydrate sample gives a wrong answer.
9.6 Elemental ion versus salt mass
The mass of a salt is not the mass of its metal ion. For calcium chloride dihydrate, elemental calcium fraction is approximately 40.08/147.02 = 0.2726.
Thus 100 mg CaCl2·2H2O contains about 27.3 mg elemental calcium, equivalent to approximately 1.36 mEq Ca2+. Label values may be rounded to 27 mg and 1.4 mEq.
| Quantity | What it counts |
|---|---|
| mg salt | Mass of the entire compound and stated hydrate |
| mg elemental ion | Mass of the ion of interest alone |
| mmol ion | Number of moles of that ion × 1000 |
| mEq ion | Millimoles multiplied by ionic valence |
| mOsm | Total osmotically counted particles × 1000 |
Always identify the species State whether the value refers to sodium, chloride, calcium or the complete salt. Specify the hydrate and solution volume. Units without a named species can be misleading.
10. Sodium chloride
10.1 Identity and properties
Formula: NaCl. Molar mass: approximately 58.44 g/mol. It occurs as white crystals or a white crystalline powder, dissolves readily in water and supplies Na+ and Cl-.
An aqueous solution of pure NaCl is broadly near neutral because it derives from a strong acid and strong base. Actual pharmaceutical solution pH depends on formulation, dissolved gases and stated specifications.
10.2 Preparation and purification
Sodium chloride can be obtained from purified brine or natural salt deposits. An instructional purification sequence is dissolution in water, removal of insoluble matter, appropriate removal of dissolved impurities, concentration, crystallization and drying.
Diagram labels: Purification principle for sodium chloride; Brine; Filter; Remove insoluble matter; Crystals; Concentrate → crystallize → dry.
Commercial pharmaceutical production controls impurities and water quality using validated processes. Crystallization alone does not establish suitability for injection or remove every contaminant.
A simple chemical representation of formation is HCl + NaOH → NaCl + H2O. This reaction explains neutralization but is not a complete manufacturing recipe.
10.3 Identification principles
Sodium gives a characteristic yellow flame under suitable flame-test conditions; contamination can interfere. Chloride reacts with silver nitrate to form a white silver chloride precipitate in an appropriately acidified test solution.
Ag+ + Cl- → AgCl↓.
AgCl is soluble in ammonia owing to complex formation. Identification tests demonstrate ionic identity; they do not alone prove purity or acceptable pharmaceutical quality.
10.4 Assay principle
Chloride can be determined by argentometric titration with standardized silver nitrate. The principal reaction is 1:1: Ag+ + Cl- → AgCl↓.
One millilitre of 0.1 mol/L AgNO3 represents 0.0001 mol NaCl, or 5.844 mg NaCl, when the reaction and method are applicable.
Actual pharmacopoeial endpoint procedures and sample preparation depend on the specified method. Interfering halides and unsuitable pH can affect results; use the prescribed assay procedure in practical work.
10.5 Uses
Sodium and chloride replacement in suitable fluid formulations.
Isotonicity adjustment of compatible pharmaceutical solutions.
A component of oral rehydration salts.
Appropriate saline solutions for specified irrigation or dilution uses. 0.9% w/v saline contains 9 g/L NaCl. Higher-concentration saline products are hypertonic and have specialized clinical uses; they are not interchangeable with ordinary isotonic saline.
10.6 Storage and quality
Store the solid in an appropriate well-closed container protected from contamination. Finished solutions require the packaging and storage conditions specified for that product.
Excess sodium or chloride administration may worsen fluid overload or electrolyte disturbances. Sodium chloride does not replace potassium and is not a complete substitute for all extracellular fluid components.
11. Potassium chloride
11.1 Identity and properties
Formula: KCl. Molar mass: approximately 74.55 g/mol. It is a white crystalline salt, soluble in water, yielding K+ and Cl-. It is used in appropriate oral and parenteral electrolyte formulations.
The hydrate issue important for calcium chloride does not justify adding water-of-crystallization mass to ordinary KCl calculations; use the actual labelled chemical form.
11.2 Preparation and identity
Potassium chloride may be obtained by purification of potassium-containing mineral salts or brines. A chemical formation equation is KOH + HCl → KCl + H2O.
Potassium produces a lilac flame under suitable conditions, though sodium contamination may mask it. Chloride gives AgCl with silver nitrate in the appropriate identification test.
These are chemical identity principles rather than a complete pharmaceutical specification. A chloride test by itself cannot distinguish KCl from NaCl or CaCl2.
11.3 Uses and physiological basis
KCl supplies potassium when replacement is required. It is used in suitable formulations for potassium depletion and is a constituent of ORS.
Potassium supports resting membrane potential and cardiac electrical activity. Deficiency and excess may both cause serious disturbances; replacement must account for the measured deficit and renal handling.
11.4 Pharmaceutical precautions
Concentrated KCl injection is a concentrate for dilution into a suitable compatible infusion formulation. It must not be given as an undiluted IV push. Complete mixing and controlled administration are essential.
Oral preparations and IV concentrates are different pharmaceutical products. Oral solutions may irritate the gastrointestinal tract and have product-specific dilution instructions. Do not infer administration instructions from a mass calculation alone.
11.5 Composition calculation
A solution containing 1.00 g KCl has 1000/74.55 = 13.41 mmol KCl, supplying 13.41 mEq K+ and 13.41 mEq Cl-.
For a specified final volume, divide by litres to obtain mEq/L. For example, 1.00 g in 0.500 L corresponds to approximately 26.8 mEq/L of each ion; this is an arithmetic example, not a treatment prescription.
11.6 Storage
Store the solid in a suitable well-closed container. Injectable concentrates require clear identification and controlled handling because confusion with diluents or ready-to-use fluids can be dangerous.
Comparison NaCl supplies the principal extracellular cation. KCl supplies the principal intracellular cation. Their matching chloride anion does not make the salts interchangeable.
12. Calcium chloride
12.1 Identity and chemical forms
Anhydrous formula: CaCl2; molar mass approximately 110.98 g/mol. Dihydrate formula: CaCl2·2H2O; molar mass approximately 147.02 g/mol.
Calcium chloride is a white crystalline, hygroscopic salt and can be deliquescent. It is freely soluble in water; dissolution can release considerable heat. Water of crystallization and absorbed moisture affect weighing and composition calculations.
12.2 Formation and identity
A formation reaction is CaCO3 + 2HCl → CaCl2 + CO2↑ + H2O. This represents acid reaction with a carbonate; purification and control of the actual hydrate form are additional production steps.
Calcium can be identified through suitable calcium-ion reactions, such as formation of calcium oxalate with oxalate under appropriate conditions. Chloride is identified separately by AgCl formation.
Ca2+ + C2O4^2- → CaC2O4↓.
The salt’s calcium and chloride tests establish different parts of its identity. Carbonate or phosphate can precipitate calcium under suitable conditions and are important compatibility considerations.
12.3 Physiological function and uses
Calcium supports muscle contraction, neurotransmitter release, coagulation and signalling. Appropriate calcium chloride products are used when calcium replacement is clinically indicated, including situations requiring a prompt rise in calcium.
Calcium chloride supplies more elemental calcium per gram than some other calcium salts. Compare products using elemental calcium or mEq of Ca2+, not equal masses of unrelated salts.
12.4 Injectable form
A 10% w/v calcium chloride dihydrate product contains 100 mg salt/mL, approximately 27 mg elemental calcium/mL or about 1.4 mEq Ca2+/mL, subject to label rounding.
Such a preparation is hypertonic. Leakage outside the intended vascular route can injure tissue. Route, rate, compatibility and monitoring are clinical decisions based on the actual product; no dose should be inferred from this concentration description.
12.5 Compatibility and storage
Calcium may form insoluble salts with phosphate or carbonate.
Assess compatibility with other medicines and infusion fluids before admixture.
Protect the solid from moisture in a tightly closed suitable container.
Do not substitute anhydrous and hydrated masses without recalculation.
12.6 Worked hydrate comparison
One gram of anhydrous CaCl2 contains 1000/110.98 = 9.01 mmol salt and about 18.0 mEq Ca2+.
One gram of CaCl2·2H2O contains 1000/147.02 = 6.80 mmol salt and about 13.6 mEq Ca2+.
The same mass gives different calcium amounts because the dihydrate includes two water molecules per formula unit.
| Salt | Characteristic examination point |
|---|---|
| NaCl | 0.9% w/v reference isotonic saline; Na+ and Cl- replacement |
| KCl | Potassium replacement; concentrated injection requires dilution |
| CaCl2 | Hydrate form matters; Ca2+ carries two charges; moisture sensitive |
13. Oral Rehydration Salts
13.1 Meaning and purpose
ORS is a defined mixture of glucose and electrolytes dissolved in the specified amount of water to provide an oral rehydration solution. It helps replace water and electrolytes lost in diarrhoea.
Glucose assists sodium absorption through intestinal coupled transport, and water follows the absorbed solutes. The solution is intended for oral use; it is not an injectable formulation.
13.2 Reduced-osmolarity formula
The widely used reduced-osmolarity formulation below is expressed for 1 litre of prepared solution. A commercial sachet may be designed for another volume; follow its stated dilution volume.
| Ingredient | Amount per litre |
|---|---|
| Sodium chloride | 2.6 g |
| Potassium chloride | 1.5 g |
| Trisodium citrate dihydrate | 2.9 g |
| Glucose, anhydrous | 13.5 g |
| Total dry ingredients | 20.5 g |
The citrate form is Na3C6H5O7·2H2O. Glucose monohydrate has a different molar mass from anhydrous glucose and cannot be substituted gram-for-gram without a specified equivalent conversion.
13.3 Ionic and glucose composition
| Species | Approximate mmol/L |
|---|---|
| Na+ | 75 |
| K+ | 20 |
| Cl- | 65 |
| Citrate3- | 10 |
| Glucose | 75 |
The total nominal osmolarity is 245 mOsm/L: 75 + 20 + 65 + 10 + 75. The constituents are counted as dissolved species; do not count sodium chloride again after counting its ions.
Electrical charge also balances: positive charge ≈ 75 + 20 = 95 mEq/L; negative charge ≈ 65 + (3 × 10) = 95 mEq/L.
13.4 Role of each constituent
Sodium chloride: supplies sodium and chloride lost with fluid.
Potassium chloride: replaces potassium losses.
Glucose: supports coupled sodium absorption and contributes osmotic particles.
Citrate: supplies base equivalents after metabolism and improves the formulation’s acid-base contribution.
13.5 Absorption mechanism
The intestinal apical membrane faces the lumen. Sodium and glucose enter absorptive cells together through a coupled transporter. A basolateral sodium-potassium pump maintains the sodium gradient; glucose exits toward the interstitial compartment through a glucose transporter.
Water is absorbed through transcellular and paracellular pathways in response to the resulting gradients. Coupled sodium-glucose absorption can remain effective in diarrhoeal illness, which explains the usefulness of ORS.
Diagram labels: Intestinal sodium-glucose absorption; Intestinal lumen; Na+ + glucose; Brush border; SGLT1; Nucleus; Glucose; Na+ out; K+ in; Na+/K+ pump; Glucose exit; Interstitium → circulation; Water follows through available pathways.
13.6 Preparation and handling principles
Use the full sachet and its specified amount of safe water. Incorrect dilution changes both electrolyte concentration and osmolarity. Do not add extra salt or sugar, and do not assume every sachet is for 1 L.
Keep the prepared solution covered and follow the product’s time and storage instructions. Prepared ORS is generally used within 24 hours; remaining solution is discarded rather than repeatedly topped up.
Dry ingredients require packaging that protects against moisture and contamination. Correct labelling should make the dilution volume clear.
13.7 Important distinctions
ORS replenishes fluid and electrolytes; it does not itself eradicate the cause of diarrhoea. Severe dehydration, shock or inability to take oral fluid requires clinical assessment and may require other fluid management.
Sports drinks, sweetened beverages and plain glucose water are not automatically equivalent to a defined ORS formula. Excess sugar can increase the osmotic load rather than improve rehydration.
13.8 Composition check numerical
2.6 g NaCl contributes 2600/58.44 = 44.5 mmol each of Na+ and Cl-. 1.5 g KCl contributes 1500/74.55 = 20.1 mmol each of K+ and Cl-.
2.9 g trisodium citrate dihydrate, molar mass approximately 294.10 g/mol, contributes about 9.86 mmol citrate and 29.6 mmol Na+. Thus sodium totals approximately 74.1 mmol/L and chloride approximately 64.6 mmol/L, consistent with the rounded formula values.
13.5 g anhydrous glucose, molar mass approximately 180.16 g/mol, contributes 74.9 mmol/L. Minor differences reflect rounding of the ingredient masses and declared ionic values.
Exam answer structure Definition → formula table → role of ingredients → sodium-glucose transport mechanism → correct dilution and storage principles.
14. Physiological acid-base balance
14.1 Normal range and meaning
Arterial blood pH is normally maintained within approximately 7.35–7.45. A pH below this range is acidemia; a pH above it is alkalemia.
Acidosis is a process tending to lower pH, whereas alkalosis is a process tending to raise it. More than one process may coexist, and compensation can modify the measured pH.
Cellular reactions continually produce acids, including CO2-associated acid and nonvolatile acids. Regulation requires immediate chemical buffering, respiratory CO2 control and renal acid-base handling.
14.2 Chemical buffer systems
| System | Principal relevance |
|---|---|
| Bicarbonate / dissolved CO2 | Major regulated extracellular buffer system |
| Phosphate | Intracellular and urinary buffering |
| Proteins | Ionizable groups in cells and plasma |
| Haemoglobin | Important erythrocyte buffer during CO2 transport |
These systems are linked rather than isolated containers. Buffering limits the immediate pH change but does not by itself remove the body’s acid load.
14.3 Bicarbonate system
CO2 + H2O ⇌ H2CO3 ⇌ H+ + HCO3-.
Carbonic acid formation and breakdown are facilitated by carbonic anhydrase, particularly in erythrocytes and relevant tissues. In clinical acid-base calculations, dissolved CO2 is used with an apparent constant rather than treating all CO2 as actual H2CO3.
For plasma near 37°C, the useful approximate relationship is:
pH = 6.1 + log10([HCO3-]/(0.03 × PaCO2)).
[HCO3-] is in mmol/L and PaCO2 in mmHg; 0.03 has the corresponding solubility units. Do not use the numerical coefficient with a different pressure unit without conversion.
14.4 Worked physiological calculation
Given HCO3- = 24 mmol/L and PaCO2 = 40 mmHg:
Dissolved CO2 term = 0.03 × 40 = 1.20 mmol/L.
Ratio = 24/1.20 = 20.
pH = 6.1 + log10(20) = 7.40 approximately.
The bicarbonate-to-dissolved-CO2 ratio is about 20:1 in this example. The body can maintain this ratio through separate regulation of bicarbonate and CO2.
14.5 Respiratory regulation
Ventilation controls CO2 removal. Increased ventilation generally lowers PaCO2 and tends to raise pH; reduced effective ventilation raises PaCO2 and tends to lower pH.
The lungs provide relatively rapid adjustment but do not remove nonvolatile acids directly. Ventilation must be interpreted in relation to metabolic production and physiological constraints.
14.6 Renal regulation
The kidneys reclaim filtered bicarbonate, generate new bicarbonate linked to acid excretion, and excrete acid as titratable acid and ammonium. These processes support longer-term acid-base control.
Reclaiming filtered bicarbonate prevents loss of existing buffer; generating new bicarbonate replaces buffer consumed by nonvolatile acid. These are related but distinct processes.
Diagram labels: Renal acid handling: tubular section; Tubular lumen; Tubular cell; Filtered; HCO3-; H+; H2CO3; CO2; CO2 + H2O; H+ + HCO3-; To blood; HCO3-; Acid excretion; NH4+ and buffered titratable acid; Diagram emphasizes bicarbonate reclamation.
14.7 Three levels of defence
Chemical buffers: act immediately by binding or releasing H+.
Lungs: alter CO2 elimination over a relatively rapid timescale.
Kidneys: alter bicarbonate handling and net acid excretion over hours to days. The response times overlap, and disease may impair one or more mechanisms. Do not interpret a buffer equation as a full description of a patient’s condition.
15. Major acid-base disturbances
15.1 Classification
A primary change in bicarbonate is described as metabolic; a primary change in PaCO2 is described as respiratory. The direction of the initial change determines acidosis or alkalosis.
| Primary disorder | Main change and expected compensation direction |
|---|---|
| Metabolic acidosis | HCO3- decreases; ventilation tends to lower PaCO2 |
| Metabolic alkalosis | HCO3- increases; PaCO2 may rise with compensation |
| Respiratory acidosis | PaCO2 increases; kidneys tend to increase HCO3- |
| Respiratory alkalosis | PaCO2 decreases; kidneys tend to decrease HCO3- |
These are directional teaching rules. Expected quantitative compensation depends on the disorder and its duration; a mixed disturbance may produce a different pattern.
15.2 Metabolic acidosis
Loss of bicarbonate, accumulation of nonvolatile acids or reduced renal acid excretion can reduce the bicarbonate/CO2 ratio. Examples include substantial diarrhoeal bicarbonate loss, acid accumulation in ketoacidosis and impaired renal acid elimination.
Respiratory compensation tends to lower PaCO2. It limits the pH fall but does not correct the underlying metabolic cause.
15.3 Metabolic alkalosis
A primary rise in bicarbonate relative to CO2 raises pH. Loss of gastric acid in prolonged vomiting is a common teaching example. Renal handling, chloride balance and volume status influence persistence.
Respiratory compensation tends toward CO2 retention but is physiologically limited. It should not be described as unrestricted cessation of breathing.
15.4 Respiratory acidosis
Reduced effective alveolar ventilation allows CO2 to accumulate. The bicarbonate/CO2 ratio decreases and pH tends to fall. Chronic compensation includes increased renal bicarbonate retention and acid excretion.
An acute CO2 rise and a longstanding CO2 rise do not produce the same bicarbonate response. The duration matters when interpreting values.
15.5 Respiratory alkalosis
Excess CO2 elimination lowers PaCO2 and raises the bicarbonate/CO2 ratio. Sustained respiratory alkalosis is accompanied by renal adjustment that lowers bicarbonate.
Hyperventilation can occur in different conditions; the acid-base classification alone does not establish its cause.
15.6 Reading a simple example
If pH is low and bicarbonate is primarily low, consider metabolic acidosis. If PaCO2 is also lower, its direction is compatible with respiratory compensation; further assessment is needed to determine whether compensation is appropriate.
If pH is low and PaCO2 is primarily high, consider respiratory acidosis. An elevated bicarbonate may reflect compensation or an additional process, depending on magnitude and timing.
15.7 Common errors
Calling every low bicarbonate value metabolic acidosis without considering respiratory alkalosis or a mixed state.
Calling compensation a second primary disorder solely because another value changes.
Assuming a near-normal pH excludes an acid-base disorder.
Treating acidosis and acidemia as identical terms.
Confusing ion replacement with correction of the entire acid-base problem.
Scope for examinations Know the four categories, the primary variable and the expected compensation direction. Clinical diagnosis requires the full history, laboratory data and assessment; these notes explain principles rather than prescribing treatment.
16. Integrated revision and calculations
16.1 Connecting pH and electrolytes
The bicarbonate system links a physiological anion to pH regulation. Sodium and chloride influence fluid composition; potassium and calcium influence excitable tissues. A replacement salt changes more than one aspect of a formulation because it supplies both cations and anions.
Adding buffer salts also changes the total dissolved-particle content. A buffer composition cannot be omitted from an isotonicity calculation merely because its main purpose is pH control.
16.2 Worked integrated buffer example
A weak acid with pKa 4.80 is formulated with an A-/HA mole ratio of 1.50. Its approximate buffer pH is 4.80 + log10(1.50) = 4.98.
If the concentrations of both partners are doubled while maintaining the ratio, the ideal calculated pH remains about 4.98, but buffer capacity and osmotic contribution increase. Actual pH may shift because of nonideal effects.
16.3 Worked integrated tonicity example
For 50 mL, ingredient X contributes 0.060 g NaCl equivalent and buffer ingredients together contribute 0.045 g. Target = 0.009 × 50 = 0.450 g.
NaCl to add = 0.450 − 0.060 − 0.045 = 0.345 g.
If the buffer contribution had been ignored, the result would be 0.390 g, an excess of 0.045 g. This illustrates why every relevant ingredient must be accounted for.
16.4 Worked electrolyte example
An illustrative solution contains 0.5844 g NaCl and 0.37275 g KCl. These supply 10.0 mmol Na+, 5.0 mmol K+ and 15.0 mmol Cl-.
For monovalent ions these are also 10.0, 5.0 and 15.0 mEq, respectively. Positive and negative ionic charges balance. Ideal total particle amount is 30.0 milliosmoles before division by the final volume.
16.5 Worked physiological ratio example
Keep PaCO2 at 40 mmHg and reduce bicarbonate from 24 to 12 mmol/L for an instructional uncompensated comparison.
pH = 6.1 + log10(12/1.20) = 7.10 approximately.
This demonstrates the direction of a bicarbonate change with CO2 held fixed. Real physiology usually includes compensatory changes, so the example is a controlled calculation rather than a prediction for every patient.
16.6 Short-answer writing pattern
For a definition, give the exact meaning and one relevant example. For a comparison, use the same criteria on both sides. For a numerical, show formula, substitution, result, units and assumptions. For a salt, include formula, properties, identification principle, uses and storage.
For a labelled mechanism, point arrows to the actual membrane, cell component or apparatus part. For an acid-base disorder, identify the primary variable first and then explain compensation direction.
16.7 High-yield distinction table
| Often confused | Correct distinction |
|---|---|
| Strong / concentrated | Ionization tendency / amount per volume |
| pH / capacity | Acid-base state / resistance to change |
| Iso-osmotic / isotonic | Particle concentration / sustained cell-volume effect |
| Salt mg / ion mEq | Compound mass / ionic charge amount |
| NaCl / KCl | Different cations and replacement functions |
| Anhydrous / dihydrate | Different molar masses and calcium content |
| ORS / IV fluid | Defined oral mixture / parenteral product |
| Acidosis / acidemia | pH-lowering process / measured low blood pH |
Quick Revision
Acid donates H+; base accepts H+ in the proton-transfer model.
pH ≈ −log10[H+] for dilute ideal solutions.
pH + pOH = pKw; approximately 14 at 25°C.
Acid buffer: pH = pKa + log10(A-/HA).
Basic buffer: pOH = pKb + log10(BH+/B).
Do stoichiometry before calculating pH after adding acid or base.
Buffer capacity increases with total buffer concentration.
Tonicity is the sustained effect on cell volume.
NaCl required: 0.009V − ΣwE grams, V in mL.
White–Vincent: Viso = 111.1ΣwE mL.
Na+ dominates extracellular cations; K+ intracellular cations.
mEq = mmol × absolute ionic valence.
Specify CaCl2 or CaCl2·2H2O before calculating calcium.
Reduced-osmolarity ORS: nominal 245 mOsm/L.
Arterial pH: approximately 7.35–7.45.
Chemical buffers, lungs and kidneys act together.
Numerical practice
1. pKa 4.76; A-/HA = 3.0. Find pH.
2. For 20 mL, ΣwE = 0.050 g. Find NaCl to add.
3. Convert 149.1 mg KCl to mEq K+.
4. Calculate pH for HCO3- 24 mmol/L and PaCO2 40 mmHg.
Answers: 1. 5.24; 2. 0.130 g; 3. 2.00 mEq; 4. approximately 7.40.
Examination Questions
Long answers
1. Explain buffer action, derive the acid-buffer equation and solve a numerical.
2. Define isotonicity and explain NaCl-equivalent, freezing-point and volume methods.
3. Describe major physiological electrolytes and their functions.
4. Write the ORS formula, ingredient functions and absorption mechanism.
5. Explain physiological acid-base regulation and the four major disturbances.
Short notes
pH scale and pharmaceutical significance.
Buffer range versus buffer capacity.
IV and ophthalmic tonicity considerations.
Sodium chloride: properties, identity and assay principle.
Potassium chloride and concentrate handling.
Calcium chloride: hydrate form and elemental calcium.
Bicarbonate, phosphate and protein buffers.
Final self-check
Can you explain why a buffer is not perfectly constant, why iso-osmotic need not mean isotonic, and why equal salt masses need not supply equal mEq?
Can you draw a biconcave erythrocyte, label an intestinal absorptive cell and identify the actual direction of water or ion movement?
NotesGallery Revise the green tables and equations, redraw the labelled mechanisms, and solve the examples independently. Keep units, chemical forms and assumptions visible in every answer.